Report cover image

Pharmaceuticals Global Industry Guide 2020-2029

Publisher MarketLine
Published Nov 24, 2025
SKU # MTLN20790953

Description

Pharmaceuticals Global Industry Guide 2020-2029

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
  • By disease type, the market is segmented into oncology drugs, anti-infective drugs, central nervous system drugs, cardiovascular disease drugs, dermatology drugs, respiratory drugs, and others. The scope of others includes diabetes drugs, anti-allergic drugs, gastrointestinal drugs, ophthalmic drugs, renal diseases drugs, hematological disorders drugs, infertility conditions drugs, and women’s health diseases drugs, etc.
  • All market data and forecasts are based on nominal prices, and all currency conversions used in the creation of this report have been calculated using yearly average exchange rates. The USD values may show a declining trend for a few countries such as Argentina, Turkey, Nigeria, Egypt, and Russia. This is primarily because of the impact of exchange rates considered.
  • The global pharmaceuticals market recorded revenues of $1,437.5 billion in 2024, representing a compound annual growth rate (CAGR) of 4.0% between 2019 and 2024.
  • The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $197.2 billion, equivalent to 13.7% of the market's overall value.
  • The global pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.7%.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the global pharmaceuticals market by value in 2024?
  • What will be the size of the global pharmaceuticals market in 2029?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • What are the main segments that make up the global pharmaceuticals market?

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Competitive landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Pharmaceuticals in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Pharmaceuticals in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Pharmaceuticals in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Pharmaceuticals in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Pharmaceuticals in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Pharmaceuticals in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Pharmaceuticals in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Pharmaceuticals in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Pharmaceuticals in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Pharmaceuticals in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Pharmaceuticals in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Pharmaceuticals in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Company Profiles
30.1. Johnson & Johnson
30.2. Merck & Co Inc
30.3. AbbVie Inc
30.4. Pfizer Inc
30.5. Sinopharm Group Co Ltd
30.6. Shanghai Pharmaceuticals Holding Co Ltd
30.7. CSPC Pharmaceutical Group Ltd
30.8. Takeda Pharmaceutical Co Ltd
30.9. Novartis AG
30.10. AstraZeneca Plc
30.11. GSK plc
30.12. F. Hoffmann-La Roche Ltd
30.13. Sanofi
30.14. Laboratoires Pierre Fabre SA
30.15. Les Laboratoires Servier SAS
30.16. Ipsen SA
30.17. Bayer AG
30.18. Boehringer Ingelheim International GmbH
30.19. Fresenius Medical Care AG & Co KGaA
30.20. Merck KGaA
30.21. CSL Ltd
30.22. Ramsay Health Care Ltd
30.23. Mayne Pharma Group Ltd
30.24. Ache Laboratorios Farmaceuticos SA
30.25. EMS SA
30.26. Hypera SA
30.27. Eurofarma Laboratorios SA
30.28. Apotex Inc
30.29. Bausch Health Companies Inc
30.30. Jiangsu Hengrui Pharmaceuticals Co Ltd
30.31. Sun Pharmaceutical Industries Ltd
30.32. Lupin Ltd
30.33. Cipla Ltd
30.34. Dr. Reddy's Laboratories Ltd
30.35. PT Kimia Farma Tbk
30.36. PT Kalbe Farma Tbk
30.37. PT Tempo Scan Pacific Tbk
30.38. A. Menarini Industrie Farmaceutiche Riunite Srl
30.39. Recordati SpA
30.40. Chiesi Farmaceutici SpA
30.41. Astellas Pharma Inc
30.42. Daiichi Sankyo Co Ltd
30.43. Otsuka Holdings Co Ltd
30.44. Genomma Lab Internacional SAB de CV
30.45. Pharmstandard
30.46. Binnopharm Group
30.47. OTC Pharma International BV
30.48. H. Lundbeck AS
30.49. Novo Nordisk AS
30.50. Aspen Pharmacare Holdings Ltd
30.51. Adcock Ingram Holdings Ltd
30.52. Chong Kun Dang Pharmaceutical Corp.
30.53. Hanmi Pharmaceuticals Co Ltd
30.54. Celltrion Inc
30.55. Yuhan Corp
30.56. Almirall SAS
30.57. Grifols SA
30.58. Laboratorios Farmaceuticos Rovi SA
30.59. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
30.60. Deva Holding AS
31 Appendix
31.1. Methodology
31.2. About MarketLine
List of Tables
Table 1: Global pharmaceuticals market value: $ million, 2019-24
Table 2: Global pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Global pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Global pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Global pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Global Size of Population (Million), 2020-24
Table 7: Global Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 8: Global GDP (Current Prices, $ Billion), 2020-24
Table 9: Global Inflation, 2020-24
Table 10: Global Consumer Price Index (Absolute), 2020-24
Table 11: Global Exchange Rate, 2019-24
Table 12: Asia-Pacific pharmaceuticals market value: $ million, 2019-24
Table 13: Asia-Pacific pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 14: Asia-Pacific pharmaceuticals market category segmentation: $ million, 2019-24
Table 15: Asia-Pacific pharmaceuticals market geography segmentation: $ million, 2024
Table 16: Asia-Pacific pharmaceuticals market value forecast: $ million, 2024-29
Table 17: Europe pharmaceuticals market value: $ million, 2019-24
Table 18: Europe pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 19: Europe pharmaceuticals market category segmentation: $ million, 2019-24
Table 20: Europe pharmaceuticals market geography segmentation: $ million, 2024
Table 21: Europe pharmaceuticals market value forecast: $ million, 2024-29
Table 22: Europe Size of Population (Million), 2020-24
Table 23: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 24: Europe GDP (Current Prices, $ Billion), 2020-24
Table 25: Europe Inflation, 2020-24
Table 26: Europe Consumer Price Index (Absolute), 2020-24
Table 27: Europe Exchange Rate, 2019-24
Table 28: France pharmaceuticals market value: $ million, 2019-24
Table 29: France pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 30: France pharmaceuticals market category segmentation: $ million, 2019-24
Table 31: France pharmaceuticals market geography segmentation: $ million, 2024
Table 32: France pharmaceuticals market value forecast: $ million, 2024-29
Table 33: France Size of Population (Million), 2020-24
Table 34: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 35: France GDP (Current Prices, $ Billion), 2020-24
Table 36: France Inflation, 2020-24
Table 37: France Consumer Price Index (Absolute), 2020-24
Table 38: France Exchange Rate, 2019-24
Table 39: Germany pharmaceuticals market value: $ million, 2019-24
Table 40: Germany pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 41: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Table 42: Germany pharmaceuticals market geography segmentation: $ million, 2024
Table 43: Germany pharmaceuticals market value forecast: $ million, 2024-29
Table 44: Germany Size of Population (Million), 2020-24
Table 45: Germany Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 46: Germany GDP (Current Prices, $ Billion), 2020-24
Table 47: Germany Inflation, 2020-24
Table 48: Germany Consumer Price Index (Absolute), 2020-24
Table 49: Germany Exchange Rate, 2019-24
Table 50: Italy pharmaceuticals market value: $ million, 2019-24
Table 51: Italy pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 52: Italy pharmaceuticals market category segmentation: $ million, 2019-24
Table 53: Italy pharmaceuticals market geography segmentation: $ million, 2024
Table 54: Italy pharmaceuticals market value forecast: $ million, 2024-29
Table 55: Italy Size of Population (Million), 2020-24
Table 56: Italy Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 57: Italy GDP (Current Prices, $ Billion), 2020-24
Table 58: Italy Inflation, 2020-24
Table 59: Italy Consumer Price Index (Absolute), 2020-24
Table 60: Italy Exchange Rate, 2019-24
Table 61: Japan pharmaceuticals market value: $ million, 2019-24
Table 62: Japan pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 63: Japan pharmaceuticals market category segmentation: $ million, 2019-24
Table 64: Japan pharmaceuticals market geography segmentation: $ million, 2024
Table 65: Japan pharmaceuticals market value forecast: $ million, 2024-29
Table 66: Japan Size of Population (Million), 2020-24
Table 67: Japan Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 68: Japan GDP (Current Prices, $ Billion), 2020-24
Table 69: Japan Inflation, 2020-24
Table 70: Japan Consumer Price Index (Absolute), 2020-24
Table 71: Japan Exchange Rate, 2019-24
Table 72: Australia pharmaceuticals market value: $ million, 2019-24
Table 73: Australia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 74: Australia pharmaceuticals market category segmentation: $ million, 2019-24
Table 75: Australia pharmaceuticals market geography segmentation: $ million, 2024
Table 76: Australia pharmaceuticals market value forecast: $ million, 2024-29
Table 77: Australia Size of Population (Million), 2020-24
Table 78: Australia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 79: Australia GDP (Current Prices, $ Billion), 2020-24
Table 80: Australia Inflation, 2020-24
Table 81: Australia Consumer Price Index (Absolute), 2020-24
Table 82: Australia Exchange Rate, 2019-24
Table 83: Canada pharmaceuticals market value: $ million, 2019-24
Table 84: Canada pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 85: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Table 86: Canada pharmaceuticals market geography segmentation: $ million, 2024
Table 87: Canada pharmaceuticals market value forecast: $ million, 2024-29
Table 88: Canada Size of Population (Million), 2020-24
Table 89: Canada Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 90: Canada GDP (Current Prices, $ Billion), 2020-24
Table 91: Canada Inflation, 2020-24
Table 92: Canada Consumer Price Index (Absolute), 2020-24
Table 93: Canada Exchange Rate, 2019-24
Table 94: China pharmaceuticals market value: $ million, 2019-24
Table 95: China pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 96: China pharmaceuticals market category segmentation: $ million, 2019-24
Table 97: China pharmaceuticals market geography segmentation: $ million, 2024
Table 98: China pharmaceuticals market value forecast: $ million, 2024-29
Table 99: China Size of Population (Million), 2020-24
Table 100: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 101: China GDP (Current Prices, $ Billion), 2020-24
Table 102: China Inflation, 2020-24
Table 103: China Consumer Price Index (Absolute), 2020-24
Table 104: China Exchange Rate, 2019-24
Table 105: Netherlands pharmaceuticals market value: $ million, 2019-24
Table 106: Netherlands pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 107: Netherlands pharmaceuticals market category segmentation: $ million, 2019-24
Table 108: Netherlands pharmaceuticals market geography segmentation: $ million, 2024
Table 109: Netherlands pharmaceuticals market value forecast: $ million, 2024-29
Table 110: Netherlands Size of Population (Million), 2020-24
List of Figures
Figure 1: Global pharmaceuticals market value: $ million, 2019-24
Figure 2: Global pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Global pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Global pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the global pharmaceuticals market, 2024
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2024
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2024
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2024
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2024
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2024
Figure 11: Asia-Pacific pharmaceuticals market value: $ million, 2019-24
Figure 12: Asia-Pacific pharmaceuticals market category segmentation: $ million, 2019-24
Figure 13: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ million, 2024-29
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2024
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2024
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2024
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2024
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2024
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2024
Figure 21: Europe pharmaceuticals market value: $ million, 2019-24
Figure 22: Europe pharmaceuticals market category segmentation: $ million, 2019-24
Figure 23: Europe pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 24: Europe pharmaceuticals market value forecast: $ million, 2024-29
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2024
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2024
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2024
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2024
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2024
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2024
Figure 31: France pharmaceuticals market value: $ million, 2019-24
Figure 32: France pharmaceuticals market category segmentation: $ million, 2019-24
Figure 33: France pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 34: France pharmaceuticals market value forecast: $ million, 2024-29
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2024
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2024
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2024
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2024
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2024
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2024
Figure 41: Germany pharmaceuticals market value: $ million, 2019-24
Figure 42: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Figure 43: Germany pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 44: Germany pharmaceuticals market value forecast: $ million, 2024-29
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2024
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2024
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2024
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2024
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2024
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2024
Figure 51: Italy pharmaceuticals market value: $ million, 2019-24
Figure 52: Italy pharmaceuticals market category segmentation: $ million, 2019-24
Figure 53: Italy pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 54: Italy pharmaceuticals market value forecast: $ million, 2024-29
Figure 55: Forces driving competition in the pharmaceuticals market in Italy, 2024
Figure 56: Drivers of buyer power in the pharmaceuticals market in Italy, 2024
Figure 57: Drivers of supplier power in the pharmaceuticals market in Italy, 2024
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2024
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2024
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2024
Figure 61: Japan pharmaceuticals market value: $ million, 2019-24
Figure 62: Japan pharmaceuticals market category segmentation: $ million, 2019-24
Figure 63: Japan pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 64: Japan pharmaceuticals market value forecast: $ million, 2024-29
Figure 65: Forces driving competition in the pharmaceuticals market in Japan, 2024
Figure 66: Drivers of buyer power in the pharmaceuticals market in Japan, 2024
Figure 67: Drivers of supplier power in the pharmaceuticals market in Japan, 2024
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2024
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2024
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2024
Figure 71: Australia pharmaceuticals market value: $ million, 2019-24
Figure 72: Australia pharmaceuticals market category segmentation: $ million, 2019-24
Figure 73: Australia pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 74: Australia pharmaceuticals market value forecast: $ million, 2024-29
Figure 75: Forces driving competition in the pharmaceuticals market in Australia, 2024
Figure 76: Drivers of buyer power in the pharmaceuticals market in Australia, 2024
Figure 77: Drivers of supplier power in the pharmaceuticals market in Australia, 2024
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2024
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2024
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2024
Figure 81: Canada pharmaceuticals market value: $ million, 2019-24
Figure 82: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Figure 83: Canada pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 84: Canada pharmaceuticals market value forecast: $ million, 2024-29
Figure 85: Forces driving competition in the pharmaceuticals market in Canada, 2024
Figure 86: Drivers of buyer power in the pharmaceuticals market in Canada, 2024
Figure 87: Drivers of supplier power in the pharmaceuticals market in Canada, 2024
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2024
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2024
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2024
Figure 91: China pharmaceuticals market value: $ million, 2019-24
Figure 92: China pharmaceuticals market category segmentation: $ million, 2019-24
Figure 93: China pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 94: China pharmaceuticals market value forecast: $ million, 2024-29
Figure 95: Forces driving competition in the pharmaceuticals market in China, 2024
Figure 96: Drivers of buyer power in the pharmaceuticals market in China, 2024
Figure 97: Drivers of supplier power in the pharmaceuticals market in China, 2024
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2024
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2024
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in China, 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us